Drug Trial Radar · NCT05952856
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,912
Actual
Start
Aug 10, 2023
Primary completion
Jul 28, 2025
Study completion Jul 28, 2025
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Jul 19, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the efficacy, safety, and tolerability of enlicitide decanoate in adult participants with hypercholesterolemia. The primary hypothesis is that enlicitide decanoate is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.
Conditions
- Hypercholesterolemia
- Familial Hypercholesterolemia
Interventions
Enlicitide DecanoateDrug
Oral tablet
PlaceboDrug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 24Time frame: Baseline and Week 24
- Number of Participants With One or More Adverse Events (AEs)Time frame: Up to 60 weeks
- Number of Participants Who Discontinued Study Drug Due to an AETime frame: Up to 52 weeks
Locations
168 sites in 14 countries. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC ( Site 0093)
Daphne, Alabama
G&L Research ( Site 0043)
Foley, Alabama
Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084)
Phoenix, Arizona
National Heart Institute-Research ( Site 0087)
Beverly Hills, California
Clinical Trials Research ( Site 0115)
Sacramento, California
Velocity Clinical Research, Banning ( Site 0017)
San Bernardino, California
Emerson Clinical Research Institute ( Site 0118)
Washington D.C., District of Columbia
Excel Medical Clinical Trials ( Site 0053)
Boca Raton, Florida
Alliance for Multispecialty Research, LLC ( Site 0088)
Coral Gables, Florida
Alliance for Multispecialty Research, LLC ( Site 0094)
Fort Myers, Florida
Velocity Clinical Research, Hallandale Beach ( Site 0018)
Hallandale, Florida
Jacksonville Center for Clinical Research ( Site 0049)
Jacksonville, Florida
South Broward Research ( Site 0051)
Miramar, Florida
Clinical Research Trials of Florida ( Site 0063)
Tampa, Florida
East Coast Institute for Research, LLC ( Site 0033)
Macon, Georgia
Healthcare Research Network - Chicago ( Site 0052)
Flossmoor, Illinois
Synexus Clinical Research US, Inc. ( Site 0109)
Evansville, Indiana
Midwest Institute For Clinical Research ( Site 0059)
Indianapolis, Indiana
Alliance for Multispecialty Research, LLC ( Site 0028)
Lexington, Kentucky
L-MARC Research Center ( Site 0001)
Louisville, Kentucky
Velocity Clinical Research, Covington ( Site 0068)
Covington, Louisiana
Velocity Clinical Research Rockville ( Site 0082)
Rockville, Maryland
Velocity Clinical Research, Gulfport ( Site 0039)
Gulfport, Mississippi
Healthcare Research Network - St. Louis ( Site 0054)
Hazelwood, Missouri
Jubilee Clinical Research ( Site 0106)
Las Vegas, Nevada
AB Clinical Trials ( Site 0070)
Las Vegas, Nevada
New Mexico Clinical Research & Osteoporosis Center ( Site 0005)
Albuquerque, New Mexico
Velocity Clinical Research, Syracuse ( Site 0021)
East Syracuse, New York
Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0002)
New York, New York
Lillestol Research ( Site 0026)
Fargo, North Dakota
altoona center for clinical research ( Site 0089)
Duncansville, Pennsylvania
Cardiology Consultants of Philadelphia Yardley ( Site 0097)
Yardley, Pennsylvania
Piedmont Research Partners ( Site 0090)
Fort Mill, South Carolina
Velocity Clinical Research, Greenville ( Site 0023)
Greenville, South Carolina
Coastal Carolina Research Center ( Site 0006)
North Charleston, South Carolina
Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0009)
Rapid City, South Dakota
Holston Medical Group ( Site 0048)
Kingsport, Tennessee
Alliance for Multispecialty Research, LLC ( Site 0008)
Knoxville, Tennessee
Velocity Clinical Research, Dallas ( Site 0114)
Dallas, Texas
Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0111)
Houston, Texas
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.